QCM
LENZ

Quantinno Capital Management’s LENZ Therapeutics LENZ Stock Holding History

Quantinno Capital Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Buy
137,715
+90,067
+189% +$726K ﹤0.01% 2739
2026
Q1 		$436K Buy
+47,648
New +$669K ﹤0.01% 2812

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Quantinno Capital Management's LENZ Position: Q2 2026 in Review

Quantinno Capital Management increased its LENZ Therapeutics (LENZ) stake by 189% in Q2 2026, buying an estimated $726K and bringing the position to 137,715 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

Quantinno Capital Management first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Quantinno Capital Management held 137,715 shares of LENZ Therapeutics worth $782K as of Q2 2026.
  • Quantinno Capital Management bought 90,067 LENZ Therapeutics shares in Q2 2026, an estimated $726K.
  • LENZ Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2739 holding.
  • Quantinno Capital Management first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.